{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:56:22Z","timestamp":1793926582632,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ) are classified as major mental disorders and together account for the second-highest global disease burden, and half of these patients experience symptom onset in adolescence. Several studies have reported both similar and unique features regarding the risk factors and clinical symptoms of these three disorders. However, it is still unclear whether these disorders have similar or unique metabolic characteristics in adolescents. We conducted a metabolomics analysis of plasma samples from adolescent healthy controls (HCs) and patients with MDD, BD, and SCZ. We identified differentially expressed metabolites between patients and HCs. Based on the differentially expressed metabolites, correlation analysis, metabolic pathway analysis, and potential diagnostic biomarker identification were conducted for disorders and HCs. Our results showed significant changes in plasma metabolism between patients with these mental disorders and HCs; the most distinct changes were observed in SCZ patients. Moreover, the metabolic differences in BD patients shared features with those in both MDD and SCZ, although the BD metabolic profile was closer to that of MDD than to SCZ. Additionally, we identified the metabolites responsible for the similar and unique metabolic characteristics in multiple metabolic pathways. The similar significant differences among the three disorders were found in fatty acid, steroid-hormone, purine, nicotinate, glutamate, tryptophan, arginine, and proline metabolism. Interestingly, we found unique characteristics of significantly altered glycolysis, glycerophospholipid, and sphingolipid metabolism in SCZ; lysine, cysteine, and methionine metabolism in MDD and BD; and phenylalanine, tyrosine, and aspartate metabolism in SCZ and BD. Finally, we identified five panels of potential diagnostic biomarkers for MDD-HC, BD-HC, SCZ-HC, MDD-SCZ, and BD-SCZ comparisons. Our findings suggest that metabolic characteristics in plasma vary across psychiatric disorders and that critical metabolites provide new clues regarding molecular mechanisms in these three psychiatric disorders.<\/jats:p>","DOI":"10.1038\/s41398-024-02886-z","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T12:04:28Z","timestamp":1711454668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents"],"prefix":"10.1038","volume":"14","author":[{"given":"Bangmin","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueer","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fandong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhang","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-3567","authenticated-orcid":false,"given":"Zheng-Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-0357","authenticated-orcid":false,"given":"Xinyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"2886_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392;1789\u2013858. https:\/\/doi.org\/10.1016\/s0140-6736(18)32279-7.","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"2886_CR2","doi-asserted-by":"publisher","first-page":"s5","DOI":"10.1192\/bjp.bp.112.119164","volume":"54","author":"PB Jones","year":"2013","unstructured":"Jones PB. Adult mental health disorders and their age at onset. Br J Psychiatry. 2013;54:s5\u2013s10. https:\/\/doi.org\/10.1192\/bjp.bp.112.119164.","journal-title":"Br J Psychiatry"},{"key":"2886_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jcpp.12381","volume":"56","author":"GV Polanczyk","year":"2015","unstructured":"Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56:345\u201365. https:\/\/doi.org\/10.1111\/jcpp.12381.","journal-title":"J Child Psychol Psychiatry"},{"key":"2886_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bpsc.2017.11.007","volume":"3","author":"D Bzdok","year":"2018","unstructured":"Bzdok D, Meyer-Lindenberg A. Machine learning for precision psychiatry: opportunities and challenges. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:223\u201330. https:\/\/doi.org\/10.1016\/j.bpsc.2017.11.007.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2886_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.nicl.2017.02.011","volume":"14","author":"T Wang","year":"2017","unstructured":"Wang T, Zhang X, Li A, Zhu M, Liu S, Qin W, et al. Polygenic risk for five psychiatric disorders and cross-disorder and disorder-specific neural connectivity in two independent populations. Neuroimage Clin. 2017;14:441\u20139. https:\/\/doi.org\/10.1016\/j.nicl.2017.02.011.","journal-title":"Neuroimage Clin"},{"key":"2886_CR6","doi-asserted-by":"publisher","unstructured":"Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic relationships novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019;179:1469\u201382.e11. https:\/\/doi.org\/10.1016\/j.cell.2019.11.020.","DOI":"10.1016\/j.cell.2019.11.020"},{"key":"2886_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/schbul\/sbaa094","volume":"47","author":"R Upthegrove","year":"2021","unstructured":"Upthegrove R, Lalousis P, Mallikarjun P, Chisholm K, Griffiths SL, Iqbal M, et al. The psychopathology and neuroanatomical markers of depression in early psychosis. Schizophr Bull. 2021;47:249\u201358. https:\/\/doi.org\/10.1093\/schbul\/sbaa094.","journal-title":"Schizophr Bull"},{"key":"2886_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1469-7610.2011.02443.x","volume":"52","author":"J Castro-Fornieles","year":"2011","unstructured":"Castro-Fornieles J, Baeza I, de la Serna E, Gonzalez-Pinto A, Parellada M, Graell M, et al. Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry. 2011;52:1089\u201398. https:\/\/doi.org\/10.1111\/j.1469-7610.2011.02443.x.","journal-title":"J Child Psychol Psychiatry"},{"key":"2886_CR9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/01.chi.0000164591.55942.ea","volume":"44","author":"T Ballageer","year":"2005","unstructured":"Ballageer T, Malla A, Manchanda R, Takhar J, Haricharan R. Is adolescent-onset first-episode psychosis different from adult onset? J Am Acad Child Adolesc Psychiatry. 2005;44:782\u20139. https:\/\/doi.org\/10.1097\/01.chi.0000164591.55942.ea.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2886_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1017\/s1461145710000866","volume":"13","author":"EH Wong","year":"2010","unstructured":"Wong EH, Yocca F, Smith MA, Lee CM. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters\u2019 perspective. Int J Neuropsychopharmacol. 2010;13:1269\u201384. https:\/\/doi.org\/10.1017\/s1461145710000866.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2886_CR11","doi-asserted-by":"publisher","unstructured":"Shin D, Rhee SJ. Integrating proteomic and clinical data to discriminate major psychiatric disorders: applications for major depressive disorder, bipolar disorder, and schizophrenia. Clin Transl Med. 2022;12:e929. https:\/\/doi.org\/10.1002\/ctm2.929.","DOI":"10.1002\/ctm2.929"},{"key":"2886_CR12","doi-asserted-by":"publisher","unstructured":"Guest PC, Guest FL, Martins-de SD. Making sense of blood-based proteomics and metabolomics in psychiatric research. Int J Neuropsychopharmacol. 2016;19. https:\/\/doi.org\/10.1093\/ijnp\/pyv138.","DOI":"10.1093\/ijnp\/pyv138"},{"key":"2886_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/gm233","volume":"3","author":"M Ore\u0161i\u010d","year":"2011","unstructured":"Ore\u0161i\u010d M, Tang J, Sepp\u00e4nen-Laakso T, Mattila I, Saarni SE, Saarni SI, et al. Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med. 2011;3:19. https:\/\/doi.org\/10.1186\/gm233.","journal-title":"Genome Med"},{"key":"2886_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.4101","volume":"36","author":"C Guijas","year":"2018","unstructured":"Guijas C, Montenegro-Burke JR. Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol. 2018;36:316\u201320. https:\/\/doi.org\/10.1038\/nbt.4101.","journal-title":"Nat Biotechnol"},{"key":"2886_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17:451\u20139. https:\/\/doi.org\/10.1038\/nrm.2016.25.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2886_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.969575","volume":"10","author":"S Tao","year":"2022","unstructured":"Tao S, Zhang Y, Wang Q, Qiao C, Deng W, Liang S, et al. Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles. Front Cell Dev Biol. 2022;10:969575. https:\/\/doi.org\/10.3389\/fcell.2022.969575.","journal-title":"Front Cell Dev Biol"},{"key":"2886_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376. https:\/\/doi.org\/10.1093\/schbul\/13.2.261.","journal-title":"Schizophr Bull"},{"key":"2886_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35511-y","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Jia H. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nat Commun. 2022;13:7802. https:\/\/doi.org\/10.1038\/s41467-022-35511-y.","journal-title":"Nat Commun"},{"key":"2886_CR19","doi-asserted-by":"publisher","unstructured":"Shen X, Wang R, Xiong X, Yin Y, Cai Y, Ma Z, et al. Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics. Nat Commun. 2019;10:1516. https:\/\/doi.org\/10.1038\/s41467-019-09550-x.","DOI":"10.1038\/s41467-019-09550-x"},{"key":"2886_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34537-6","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Luo M, Zhang H, Yin Y, Cai Y, Zhu ZJ. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat Commun. 2022;13:6656. https:\/\/doi.org\/10.1038\/s41467-022-34537-6.","journal-title":"Nat Commun"},{"key":"2886_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/pr060594q","volume":"6","author":"J Trygg","year":"2007","unstructured":"Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007;6:469\u201379. https:\/\/doi.org\/10.1021\/pr060594q.","journal-title":"J Proteome Res"},{"key":"2886_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/bioinformatics\/btp176","volume":"25","author":"XB Ling","year":"2009","unstructured":"Ling XB, Cohen H, Jin J, Lau I, Schilling J. FDR made easy in differential feature discovery and correlation analyses. Bioinformatics. 2009;25:1461\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btp176.","journal-title":"Bioinformatics"},{"key":"2886_CR23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/bioinformatics\/btn209","volume":"24","author":"K Strimmer","year":"2008","unstructured":"Strimmer K. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics. 2008;24:1461\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btn209.","journal-title":"Bioinformatics"},{"key":"2886_CR24","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41587-019-0233-9","volume":"37","author":"T Wilmanski","year":"2019","unstructured":"Wilmanski T, Rappaport N, Earls JC, Magis AT, Manor O, Lovejoy J, et al. Blood metabolome predicts gut microbiome \u03b1-diversity in humans. Nat Biotechnol. 2019;37:1217\u201328. https:\/\/doi.org\/10.1038\/s41587-019-0233-9.","journal-title":"Nat Biotechnol"},{"key":"2886_CR25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.ultrasmedbio.2021.02.027","volume":"47","author":"ZM Lin","year":"2021","unstructured":"Lin ZM, Chen JF, Xu FT, Liu CM, Chen JS, Wang Y, et al. Principal component regression-based contrast-enhanced ultrasound evaluation system for the management of BI-RADS US 4A breast masses: objective assistance for radiologists. Ultrasound Med Biol. 2021;47:1737\u201346. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2021.02.027.","journal-title":"Ultrasound Med Biol"},{"key":"2886_CR26","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/foods11081172","volume":"11","author":"JG Kljusuri\u0107","year":"2022","unstructured":"Kljusuri\u0107 JG, Boban A, Mucalo A. Novel application of NIR spectroscopy for non-destructive determination of \u2018Mara\u0161tina\u2019 wine parameters. Foods. 2022;11:1172. https:\/\/doi.org\/10.3390\/foods11081172.","journal-title":"Foods"},{"key":"2886_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","volume":"32","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Ma D, Yang YS, Yang F, Ding JH, Gong Y, et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 2022;32:477\u201390. https:\/\/doi.org\/10.1038\/s41422-022-00614-0.","journal-title":"Cell Res"},{"key":"2886_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6:743\u201360. https:\/\/doi.org\/10.1038\/nprot.2011.319.","journal-title":"Nat Protoc"},{"key":"2886_CR29","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Vol 39. Washington DC: American Psychiatric Association; 1994."},{"key":"2886_CR30","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Vol 5. Washington, DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2886_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.metabol.2019.04.002","volume":"95","author":"N Brunkhorst-Kanaan","year":"2019","unstructured":"Brunkhorst-Kanaan N, Klatt-Schreiner K, Hackel J, Schr\u00f6ter K, Trautmann S, Hahnefeld L, et al. Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder. Metabolism. 2019;95:65\u201376. https:\/\/doi.org\/10.1016\/j.metabol.2019.04.002.","journal-title":"Metabolism"},{"key":"2886_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fpsyt.2020.00496","volume":"11","author":"HPG Joaquim","year":"2020","unstructured":"Joaquim HPG, Costa AC, Talib LL, Dethloff F, Serpa MH, Zanetti MV, et al. Plasma metabolite profiles in first episode psychosis: exploring symptoms heterogeneity\/severity in schizophrenia and bipolar disorder cohorts. Front Psychiatry. 2020;11:496. https:\/\/doi.org\/10.3389\/fpsyt.2020.00496.","journal-title":"Front Psychiatry"},{"key":"2886_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jad.2011.09.007","volume":"136","author":"A Jadoon","year":"2012","unstructured":"Jadoon A, Chiu CC, McDermott L, Cunningham P, Frangou S, Chang CJ, et al. Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression. J Affect Disord. 2012;136:918\u201325. https:\/\/doi.org\/10.1016\/j.jad.2011.09.007.","journal-title":"J Affect Disord"},{"key":"2886_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.802710","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Zhang T, Li R, Cui ZQ, Du J, Yang JB, et al. Alterations in the plasma lipidome of adult women with bipolar disorder: a mass spectrometry-based lipidomics research. Front Psychiatry. 2022;13:802710. https:\/\/doi.org\/10.3389\/fpsyt.2022.802710.","journal-title":"Front Psychiatry"},{"key":"2886_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.885904","volume":"13","author":"TA Couttas","year":"2022","unstructured":"Couttas TA, Jieu B, Rohleder C, Leweke FM. Current state of fluid lipid biomarkers for personalized diagnostics and therapeutics in schizophrenia spectrum disorders and related psychoses: a narrative review. Front Psychiatry. 2022;13:885904. https:\/\/doi.org\/10.3389\/fpsyt.2022.885904.","journal-title":"Front Psychiatry"},{"key":"2886_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2019.08.033","volume":"226","author":"A Alqarni","year":"2020","unstructured":"Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, et al. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. Schizophr Res. 2020;226:52\u201360. https:\/\/doi.org\/10.1016\/j.schres.2019.08.033.","journal-title":"Schizophr Res"},{"key":"2886_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpsychires.2015.12.007","volume":"75","author":"BT Chhetry","year":"2016","unstructured":"Chhetry BT, Hezghia A, Miller JM, Lee S, Rubin-Falcone H, Cooper TB, et al. Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression. J Psychiatr Res. 2016;75:65\u201374. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.12.007.","journal-title":"J Psychiatr Res"},{"key":"2886_CR38","doi-asserted-by":"publisher","first-page":"e98682","DOI":"10.1371\/journal.pone.0098682","volume":"9","author":"M Maripuu","year":"2014","unstructured":"Maripuu M, Wikgren M, Karling P, Adolfsson R, Norrback KF. Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study. PLoS ONE. 2014;9:e98682. https:\/\/doi.org\/10.1371\/journal.pone.0098682.","journal-title":"PLoS ONE"},{"key":"2886_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104376","volume":"109","author":"JL Ford","year":"2019","unstructured":"Ford JL, Boch SJ, Browning CR. Hair cortisol and depressive symptoms in youth: an investigation of curvilinear relationships. Psychoneuroendocrinology. 2019;109:104376. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104376.","journal-title":"Psychoneuroendocrinology"},{"key":"2886_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jpsychires.2018.06.012","volume":"104","author":"L Ustohal","year":"2018","unstructured":"Ustohal L, Hlavacova N, Mayerova M, Ceskova E, Jezova D. Aldosterone and aldosterone\/cortisol ratio is higher in serum of long-term compared to first episode schizophrenia patients: a pilot study. J Psychiatr Res. 2018;104:46\u20139. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.06.012.","journal-title":"J Psychiatr Res"},{"key":"2886_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.psychres.2009.11.008","volume":"176","author":"J Hons","year":"2010","unstructured":"Hons J, Zirko R, Ulrychova M, Cermakova E, Doubek P, Libiger J. Glycine serum level in schizophrenia: relation to negative symptoms. Psychiatry Res. 2010;176:103\u20138. https:\/\/doi.org\/10.1016\/j.psychres.2009.11.008.","journal-title":"Psychiatry Res"},{"key":"2886_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.76","volume":"2","author":"Y He","year":"2012","unstructured":"He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, et al. Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012;2:e149. https:\/\/doi.org\/10.1038\/tp.2012.76.","journal-title":"Transl Psychiatry"},{"key":"2886_CR43","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1038\/s41380-020-0645-4","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, et al. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry. 2021;26:4265\u201376. https:\/\/doi.org\/10.1038\/s41380-020-0645-4.","journal-title":"Mol Psychiatry"},{"key":"2886_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113773","volume":"194","author":"H Chen","year":"2021","unstructured":"Chen H, Xie H, Huang S, Xiao T, Wang Z, Ni X, et al. Development of mass spectrometry-based relatively quantitative targeted method for amino acids and neurotransmitters: applications in the diagnosis of major depression. J Pharm Biomed Anal. 2021;194:113773. https:\/\/doi.org\/10.1016\/j.jpba.2020.113773.","journal-title":"J Pharm Biomed Anal"},{"key":"2886_CR45","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jpsychires.2021.08.034","volume":"142","author":"CC Bortolasci","year":"2021","unstructured":"Bortolasci CC, Turner A, Mohebbi M, Liu ZS, Ashton M, Gray L, et al. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial. J Psychiatr Res. 2021;142:376\u201383. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.08.034.","journal-title":"J Psychiatr Res"},{"key":"2886_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.psychres.2019.01.031","volume":"273","author":"MB Joshi","year":"2019","unstructured":"Joshi MB, Pai S, Balakrishnan A, Bhat M, Kotambail A, Sharma P, et al. Evidence for perturbed metabolic patterns in bipolar disorder subjects associated with lithium responsiveness. Psychiatry Res. 2019;273:252\u20139. https:\/\/doi.org\/10.1016\/j.psychres.2019.01.031.","journal-title":"Psychiatry Res"},{"key":"2886_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.neubiorev.2017.07.002","volume":"80","author":"M Ghasemi","year":"2017","unstructured":"Ghasemi M, Phillips C, Fahimi A, McNerney MW, Salehi A. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders. Neurosci Biobehav Rev. 2017;80:555\u201372. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.07.002.","journal-title":"Neurosci Biobehav Rev"},{"key":"2886_CR48","first-page":"63","volume":"11","author":"S Saleem","year":"2017","unstructured":"Saleem S, Shaukat F, Gul A, Arooj M, Malik A. Potential role of amino acids in pathogenesis of schizophrenia. Int J Health Sci. 2017;11:63\u20138.","journal-title":"Int J Health Sci"},{"key":"2886_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nbd.2009.04.004","volume":"35","author":"W Hilgier","year":"2009","unstructured":"Hilgier W, Fre\u015bko I, Klemenska E, Beresewicz A, Oja SS, Saransaari P, et al. Glutamine inhibits ammonia-induced accumulation of cGMP in rat striatum limiting arginine supply for NO synthesis. Neurobiol Dis. 2009;35:75\u201381. https:\/\/doi.org\/10.1016\/j.nbd.2009.04.004.","journal-title":"Neurobiol Dis"},{"key":"2886_CR50","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/schbul\/sbt124","volume":"40","author":"T Natsubori","year":"2014","unstructured":"Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, et al. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia. Schizophr Bull. 2014;40:1128\u201339. https:\/\/doi.org\/10.1093\/schbul\/sbt124.","journal-title":"Schizophr Bull"},{"key":"2886_CR51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","volume":"98","author":"LK Bak","year":"2006","unstructured":"Bak LK, Schousboe A, Waagepetersen HS. The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98:641\u201353. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03913.x.","journal-title":"J Neurochem"},{"key":"2886_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","volume":"112","author":"MD Lovelace","year":"2017","unstructured":"Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology. 2017;112:373\u201388. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.024.","journal-title":"Neuropharmacology"},{"key":"2886_CR53","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41380-020-00973-3","volume":"26","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Wang M. The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex. Mol Psychiatry. 2021;26:3684\u2013700. https:\/\/doi.org\/10.1038\/s41380-020-00973-3.","journal-title":"Mol Psychiatry"},{"key":"2886_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.biopsych.2022.02.003","volume":"92","author":"AFT Arnsten","year":"2022","unstructured":"Arnsten AFT, Woo E, Yang S, Wang M, Datta D. Unusual molecular regulation of dorsolateral prefrontal cortex layer III synapses increases vulnerability to genetic and environmental insults in schizophrenia. Biol Psychiatry. 2022;92:480\u201390. https:\/\/doi.org\/10.1016\/j.biopsych.2022.02.003.","journal-title":"Biol Psychiatry"},{"key":"2886_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biopsych.2006.05.031","volume":"61","author":"AA Gershon","year":"2007","unstructured":"Gershon AA, Vishne T, Grunhaus L. Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry. 2007;61:145\u201353. https:\/\/doi.org\/10.1016\/j.biopsych.2006.05.031.","journal-title":"Biol Psychiatry"},{"key":"2886_CR56","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/npp.2010.33","volume":"35","author":"CC Chen","year":"2010","unstructured":"Chen CC, Yang CH, Huang CC, Hsu KS. Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity. Neuropsychopharmacology. 2010;35:1605\u201317. https:\/\/doi.org\/10.1038\/npp.2010.33.","journal-title":"Neuropsychopharmacology"},{"key":"2886_CR57","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/cns.13731","volume":"27","author":"MS Abdallah","year":"2021","unstructured":"Abdallah MS, Ramadan AN, Omara-Reda H, Mansour NO, Elsokary MA, Elsawah HK, et al. Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder. CNS Neurosci Ther. 2021;27:1540\u20138. https:\/\/doi.org\/10.1111\/cns.13731.","journal-title":"CNS Neurosci Ther"},{"key":"2886_CR58","doi-asserted-by":"publisher","unstructured":"Rezaei F, Mesgarpour B, Jeddian A, Zeionoddini A, Mohammadinejad P, Salardini E et al. Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2017;32. https:\/\/doi.org\/10.1002\/hup.2583.","DOI":"10.1002\/hup.2583"},{"key":"2886_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/cns.12377","volume":"21","author":"J Mu\u00f1oz-Estrada","year":"2015","unstructured":"Mu\u00f1oz-Estrada J, Ben\u00edtez-King G, Berlanga C, Meza I. Altered subcellular distribution of the 75-kDa DISC1 isoform, cAMP accumulation, and decreased neuronal migration in schizophrenia and bipolar disorder: implications for neurodevelopment. CNS Neurosci Ther. 2015;21:446\u201353. https:\/\/doi.org\/10.1111\/cns.12377.","journal-title":"CNS Neurosci Ther"},{"key":"2886_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.biopsych.2017.10.014","volume":"83","author":"CR Sullivan","year":"2018","unstructured":"Sullivan CR, O\u2019Donovan SM, McCullumsmith RE, Ramsey A. Defects in bioenergetic coupling in schizophrenia. Biol Psychiatry. 2018;83:739\u201350. https:\/\/doi.org\/10.1016\/j.biopsych.2017.10.014.","journal-title":"Biol Psychiatry"},{"key":"2886_CR61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/ars.2018.7606","volume":"31","author":"Y Kim","year":"2019","unstructured":"Kim Y, Vadodaria KC, Lenkei Z, Kato T, Gage FH, Marchetto MC, et al. Mitochondria, metabolism, and redox mechanisms in psychiatric disorders. Antioxid Redox Signal. 2019;31:275\u2013317. https:\/\/doi.org\/10.1089\/ars.2018.7606.","journal-title":"Antioxid Redox Signal"},{"key":"2886_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s2215-0366(19)30416-x","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7:64\u201377. https:\/\/doi.org\/10.1016\/s2215-0366(19)30416-x.","journal-title":"Lancet Psychiatry"},{"key":"2886_CR63","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jn\/137.6.1539S","volume":"137","author":"JD Fernstrom","year":"2007","unstructured":"Fernstrom JD, Fernstrom MH. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007;137:S1539\u2013S47. https:\/\/doi.org\/10.1093\/jn\/137.6.1539S.","journal-title":"J Nutr"},{"key":"2886_CR64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fpsyt.2018.00501","volume":"9","author":"O Sommer","year":"2018","unstructured":"Sommer O, Aug RL, Schmidt AJ, Heiser P, Schulz E, Vedder H, et al. Hydrogen sulfide affects radical formation in the hippocampus of LPS treated rats and the effect of antipsychotics on hydrogen sulfide forming enzymes in human cell lines. Front Psychiatry. 2018;9:501. https:\/\/doi.org\/10.3389\/fpsyt.2018.00501.","journal-title":"Front Psychiatry"},{"key":"2886_CR65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12031-018-1218-8","volume":"67","author":"F Ghanbari","year":"2019","unstructured":"Ghanbari F, Khaksari M. Hydrogen sulfide protects hippocampal neurons against methamphetamine neurotoxicity via inhibition of apoptosis and neuroinflammation. J Mol Neurosci. 2019;67:133\u201341. https:\/\/doi.org\/10.1007\/s12031-018-1218-8.","journal-title":"J Mol Neurosci"},{"key":"2886_CR66","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/npp.2016.231","volume":"42","author":"SS Pathak","year":"2017","unstructured":"Pathak SS, Maitra S, Chakravarty S, Kumar A. Histone lysine demethylases of JMJD2 or KDM4 family are important epigenetic regulators in reward circuitry in the etiopathology of depression. Neuropsychopharmacology. 2017;42:854\u201363. https:\/\/doi.org\/10.1038\/npp.2016.231.","journal-title":"Neuropsychopharmacology"},{"key":"2886_CR67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.biopsych.2008.08.015","volume":"65","author":"S Akbarian","year":"2009","unstructured":"Akbarian S, Huang HS. Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry. 2009;65:198\u2013203. https:\/\/doi.org\/10.1016\/j.biopsych.2008.08.015.","journal-title":"Biol Psychiatry"},{"key":"2886_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7313090","volume":"2017","author":"M Herbet","year":"2017","unstructured":"Herbet M, Korga A, Gawro\u0144ska-Grzywacz M, Izdebska M, Pi\u0105tkowska-Chmiel I, Poleszak E, et al. Chronic variable stress is responsible for lipid and DNA oxidative disorders and activation of oxidative stress response genes in the brain of rats. Oxid Med Cell Longev. 2017;2017:7313090. https:\/\/doi.org\/10.1155\/2017\/7313090.","journal-title":"Oxid Med Cell Longev"},{"key":"2886_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neubiorev.2019.04.010","volume":"102","author":"C Park","year":"2019","unstructured":"Park C, Rosenblat JD, Brietzke E, Pan Z, Lee Y, Cao B, et al. Stress, epigenetics and depression: a systematic review. Neurosci Biobehav Rev. 2019;102:139\u201352. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.010.","journal-title":"Neurosci Biobehav Rev"},{"key":"2886_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1176\/appi.ps.201700145","volume":"69","author":"NJ Williams","year":"2018","unstructured":"Williams NJ, Scott L, Aarons GA. Prevalence of serious emotional disturbance among U.S. children: a meta-analysis. Psychiatr Serv. 2018;69:32\u201340. https:\/\/doi.org\/10.1176\/appi.ps.201700145.","journal-title":"Psychiatr Serv"},{"key":"2886_CR71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jad.2018.09.015","volume":"243","author":"F Rice","year":"2019","unstructured":"Rice F, Riglin L, Lomax T, Souter E, Potter R, Smith DJ, et al. Adolescent and adult differences in major depression symptom profiles. J Affect Disord. 2019;243:175\u201381. https:\/\/doi.org\/10.1016\/j.jad.2018.09.015.","journal-title":"J Affect Disord"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02886-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02886-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02886-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T12:07:26Z","timestamp":1711454846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02886-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2886"],"URL":"https:\/\/doi.org\/10.1038\/s41398-024-02886-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}